Patient info Open main menu

Sucralfate 1g/5ml Oral Suspension – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
1 g/5 ml (200 mg/ml)
Contains active substance:
ATC code:

Patient leaflet - Sucralfate 1 g/5 ml oral suspension

1. What Sucralfate Suspension is and what it is used for

Sucralfate Suspension contains a medicine called sucralfate. This belongs to a group of medicines called “Ulcer-healing” medicines. It works by forming a protective barrier over a stomach ulcer and helps stop further irritation caused by stomach acid.

Sucralfate Suspension is used to treat:

  • Stomach ulcers
  • Ulcers in your bowel
  • Infl ammation of your stomach lining

Sucralfate Suspension can also be used to prevent bleeding ulcers in seriously ill patients in hospital.

2. What you need to know before you take Sucralfate Suspension

Do not take Sucralfate Suspension:

  • If you are allergic (hypersensitive) to sucralfate or any of the other ingredients of Sucralfate Suspension (listed in Section 6). Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue
  • If you are on dialysis for kidney problems

Do not take this medicine if any of the above apply to you. If you are not sure talk to your doctor or pharmacist before taking Sucralfate Suspension.

You must not be given this medicine by injection into a vein.

Warnings and precautions

Talk to your doctor or pharmacist before taking Sucralfate Suspension if:

  • You are pregnant, trying to become pregnant or breast-feeding (see ‘Pregnancy and breast-feeding’ below)

    • You have kidney problems

If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking Sucralfate Suspension.

Other medicines and Sucralfate Suspension

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, including herbal medicines. This is because Sucralfate Suspension can aff ect the way some other medicines work. Also some other medicines can aff ect the way Sucralfate Suspension works.

In particular, before taking Sucralfate Suspension, tell your doctor or pharmacist if you are taking any of the following medicines:

  • Medicines containing citrates
  • Medicines containing aluminium
  • Medicines for stomach ulcers such as cimetidine or ranitidine
  • Medicines for infection (antibiotics) such as tetracycline, ciprofl oxacin or norfl oxacin
  • Sulpiride-used for mental health problems (psychotic episodes)
  • Digoxin-used for heart problems
  • Phenytoin-used for fi ts (epilepsy)
  • Warfarin-used for blood clots
  • Theophylline-used for asthma or other breathing problems
  • Levothyroxine-used for thyroid problems
  • Quinidine-used for heart problems
  • Ketaconazole-used for fungal infections

If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Sucralfate Suspension.

If you are taking any other medicine, leave a two hour gap between taking Sucralfate Suspension and the other medicine. For “antacid” medicines, the gap needs to be at least half an hour.

Sucralfate Suspension with food and drink

If you are being fed by a tube into your stomach, Sucralfate Suspension should be given at least one hour before or after a feed.

Pregnancy and breast-feeding

Talk to your doctor or pharmacist before taking this medicine if:

  • You are pregnant, might become pregnant or think you might be pregnant
  • You are breast-feeding or planning to breast-feed Ask your doctor or pharmacist for advice before taking any medicine if you might be pregnant.

Driving and using machines

Sucralfate Suspension may make you feel dizzy or drowsy. If you feel dizzy or drowsy, do not drive or use tools or machines while taking this medicine.

Sucralfate Suspension contains Hydroxybenzoates

  • This medicine contains sodium propyl hydroxybenzoate (E217) and sodium methyl hydroxybenzoate (E219). These may cause allergic reactions and sometimes this allergic reaction may not happen straight away.

Sulcrafate Suspension contains sodium

This medicine contains 4.4-8.8 mg sodium (found in table salt) in each dose (5-10 ml). A daily dose of 30 ml corresponds to 1.3% of the recommended maximum daily intake of sodium from the diet for an adult.

3. How to take Sucralfate Suspension

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is either:

  • 10 ml after waking up in the morning and 10 ml at bedtime or
  • 5 ml four times a day. Doses should be taken before meals and at bedtime

In seriously ill patients in hospital, the dose may be increased to 5 ml six times a day.

Taking this medicine

  • Take this medicine by mouth
  • Shake the bottle well before use
  • This medicine is usually taken for 4 to 6 weeks, but may be taken for up to 12 weeks if necessary
  • The maximum dose in a day is 40 ml

Use in children

Sucralfate Suspension is not suitable for children under 14 years old.

If you take more Sucralfate Suspension than you should

If you take more Sucralfate Suspension than you should, talk to a doctor or go to hospital straight away. Take the medicine pack with you. This is so the doctor knows what you have taken.

If you forget to take Sucralfate Suspension

  • If you forget a dose, take it as soon as you remember it. However, if it is nearly time for the next dose, skip the missed dose
  • Do not take a double dose to make up for a forgotten dose

If you stop taking Sucralfate Suspension

Do not stop taking Sucralfate Suspension without talking to your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side eff ects

Like all medicines, this Sucralfate Suspension can cause side eff ects, although not everybody gets them.

Stop taking Sucralfate Suspension and tell your doctor straight away if:

  • You have an allergic reaction. The signs include a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.

Tell a doctor or pharmacist if any of the following side eff ects gets serious or lasts longer than a few days:

  • Constipation or diarrhoea
  • Indigestion, stomach ache or wind
  • Being sick (vomiting) or feeling sick (nausea)
  • Feeling dizzy, drowsy or being unsteady on your feet
  • Back pain
  • Dry mouth
  • Headache
  • Itching

Sucralfate Suspension may cause a blockage in the digestive tract of seriously ill patients in hospital. This is a rare side eff ect.

Sucralfate Suspension may cause aluminium to build up in your body. This can cause changes in your bones such as thinning or softening, impairment of your brain or problems with your blood.

Reporting of side eff ects

If you get any side eff ects, talk to your doctor or pharmacist. This includes any possible side eff ects not listed in this leafl et. You can also report side eff ects directly via the Yellow Card Scheme at: Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side eff ects, you can help provide more information on the safety of this medicine.

5. How to store Sucralfate Suspension

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the bottle label. The expiry date refers to the last day of that month.

Do not store above 25°C.

Once opened the medicine should be used within 28 days. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throwaway any medicines you no longer use. These measures will help to protect the environment.

If your medicine becomes discoloured or shows any other signs of deterioration consult your pharmacist who will tell you what to do.

6. Contents of the pack and other information

What Sucralfate Suspension contains

  • Sucralfate Suspension contains the active substance sucralfate. Each 5ml dose contains 1g sucralfate.
  • The other ingredients contained in the Sucralfate Suspension are sodium methyl hydroxybenzoate (E219), sodium propyl hydroxybenzoate (E217), sodium dihydrogen phosphate dihydrate, xanthan gum, aniseed fl avour, caramel fl avour, saccharin sodium, glycerol 85% and deionised water.

What Sucralfate Suspension looks like and contents of the pack

Sucralfate Suspension is a white to off -white suspension with an odour of aniseed/caramel. It comes in 200 ml amber glass bottle with a child resistant screw cap and graduated measuring cup.

Manufactured by Laboratorio Chimico Farmaceutico A. Sella S.r.l., Italy.

Procured from within the EU and repackaged by the Product Licence holder:

Glenmark Pharmaceuticals Europe Limited,

Laxmi House, 2B Draycott Avenue, Kenton, Middlesex, HA3 0BU

PL 25258/0447

POM

Leafl et revision date (Ref.): 19.06.2026

To request a copy of this leafl et in Braille, large print or audio please call 0800 198 5000

PMUKP00020/A

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 25258/0447

Last revision stated in the text: 19 June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Sucralfate 1 g/5 ml oral suspension

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Sucralfate
Strength 1 g/5 ml (200 mg/ml)
Pharmaceutical form Oral suspension
White to off-white viscous suspension with an odour of aniseed/caramel.
How is it taken Oral
Excipients Saccharin sodium, Sodium dihydrogen phosphate dihydrate, Water deinonised, Glycerol, Sodium propyl hydroxybenzoate (E217), Sodium methyl hydroxybenzoate (E219), Xanthan gum, Aniseed flavour, Caramel flavour
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
After first opening: 28 days.
Storage Store below 25°C.
Drug group (ATC) Alimentary tract and metabolism
  1. A Alimentary tract and metabolism drugs
    1. A02 Drugs for acid related disorders
      1. A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
        1. A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
          1. A02BX02 sucralfate
Marketing authorisation PLPI 25258/0447
Marketing authorisation holder Glenmark Pharmaceuticals Europe Limited
Codes BNF 01030300

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.